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Abstract 
 
Accumulating evidence suggests that antenatal maternal stress is associated with altered 
behavioral and physiological outcomes in the offspring, however, whether this association is causal 
and the underlying biological mechanisms remain largely unknown. While the most studied 
mediator of maternal stress influences on the fetus has generally been cortisol, alternative novel 
markers of stress or inflammation warrant further consideration. The current investigation explored 
the influence of variations in self-reported symptoms of distress, stress hormones and 
inflammatory markers on infant birth outcomes and early stress regulation. The sample consisted 
of 104 pregnant women (mean gestational age=34.76; SD=1.12) and their healthy newborns. 
Maternal self-reported symptoms of depression and anxiety were evaluated through the Edinburgh 
Postnatal Depression Scale and the State-Trait Anxiety Inventory and levels of serum Interleukine-
6 (IL-6), C-Reactive Protein (CRP), salivary cortisol and alpha amylase (sAA) were measured in 
late pregnancy. Newborns’ cortisol and behavioral response to the heel-stick was assessed 48-72 
hours after birth. The associations between maternal stress measures and infant birth outcomes 
and stress reactivity, adjusted for potential confounders, were examined through hierarchical linear 
regressions and hierarchical linear models. Higher maternal IL-6 levels were associated with 
smaller head circumference at birth, while diurnal sAA levels were positively associated with 
birthweight. Maternal diurnal cortisol was related to newborn’s stress reactivity: a flatter infant 
cortisol response to the heel-stick was associated with greater maternal cortisol increases after 
awakening during pregnancy, while greater infant behavioural reactivity was related to a flatter 
maternal diurnal cortisol profile. The observational nature of these data does not allow for causal 
inferences but the current findings illustrate that antenatal factors related to alterations in maternal 
stress and immune response systems are associated with supporting fetal growth and neonatal 
stress reactivity. This may have implications for later health and psychological outcomes. 
 
Keywords: Pregnancy; Stress; Cortisol; Alpha-amylase; Interleukine-6 (IL-6); Birth outcomes.  
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1. Introduction 
 
Mounting evidence indicates that maternal prenatal stress is associated with an increased 
risk of altered physiological, behavioral, emotional and cognitive outcomes in offspring (Van den 
Bergh et al., 2017). Maternal depressive or anxiety symptoms have been the most common 
measures of prenatal stress (e.g. Talge et al., 2007) and findings from many community samples 
have shown that they might have a detectable impact even at subclinical levels(reviewed in Talge 
et al., 2007; Van den Bergh et al., 2017; Madigan et al., 2018), thus broadening scientific and 
public health implications.  
Notwithstanding the substantial evidence linking antenatal maternal distress to child 
outcomes, proving that this association is causal is challenging. There is a variety of confounds, 
including genetic and postnatal environmental factors, that could be related to both maternal 
distress and offspring outcomes and cause spurious associations (Rice et al., 2018). However, 
associations between prenatal stress and some indices of child development were found when 
using a prenatal cross-fostering design, which controls for maternal heritable factors (Rice et al., 
2010), and controlling for measured confounding factors, such as smoking or socioeconomic status 
(e.g. O’Connor et al., 2013), or postnatal effects, such as postnatal symptomatology (e.g. 
O’Donnell et al., 2013). Thus, it has been proposed that distress-linked alterations in the 
intrauterine environment might mediate, at least in part, the link between maternal antenatal 
distress and adverse developmental outcomes, in a process often described as “fetal 
programming” (e.g. Barker, 2004). Based on animal studies, research has focused primarily on the 
role of the maternal HPA axis. However, the weight of supporting evidence in humans is not yet 
convincing (Rakers et al., 2017) and it is now clear that complementary or alternative mechanisms 
of stress, involving, for example, the sympathetic nervous system (SNS) or the inflammatory 
response systems (IRS) warrant further consideration.  
 
1.1 Prenatal HPA axis functioning and offspring’s stress reactivity 
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Excessive fetal exposure to glucocorticoids, both synthetic and endogenous, can have 
detrimental effects in later life (Seckl & Holmes, 2007). Indeed, while the fetus is largely protected 
from cortisol exposure through the activity of the placental enzyme 11β-hydroxysteroid 
dehydrogenase type 2 (11β-HSD2), a proportion of maternal cortisol crosses the placenta and 
influences fetal development (Gitau et al., 1998). Thus, it has been hypothesized that distress-
linked elevations in maternal cortisol or impairment of the activity of 11β-HSD2, might lead to more 
cortisol passing through the placenta and directly affecting fetal development and stress 
physiology, with long-lasting consequences (O’Donnell & Meaney, 2017).  
In humans, only partial support for a link between antenatal maternal cortisol and offspring 
development has been found (reviewed in Zijlmans et al., 2015). In particular, preliminary findings 
relate higher maternal cortisol during pregnancy with lower offspring birthweight and/or shorter 
gestational age (Reynolds, 2013), although results are dependent on the gestational timing and 
methods of assessment. Additionally, evidence for an association between antenatal maternal 
cortisol and offspring stress reactivity are scarce and not entirely consistent. In general, higher 
maternal cortisol levels have been associated with greater cortisol and behavioural stress reactivity 
in infants (e.g. Davis et al., 2011; Werner et al., 2013), but studies also report inverse associations 
(O’Connor et al., 2013) or no association (e.g. Tollenaar et al., 2011).  
It has been shown that multiple diurnal cortisol measures are more strongly associated with 
psychosocial stress measures (Pruessner et al., 2003, Harville et al., 2009) and allow to obtain a 
more reliable estimate of total cortisol output (Adam & Kumari, 2009). However, only few studies 
have investigated the effect of maternal diurnal cortisol variations on infant birth outcomes (e.g. 
Kivlighan et al., 2008) or stress reactivity (Giesbrecht et al., 2017; de Weerth et al., 2013).  
   
1.2 Prenatal SNS functioning and offspring’s stress reactivity 
Although catecholamines, produced by the SNS under stress conditions, do not cross the 
placental barrier in biologically relevant concentrations (Giannakoulopoulos et al., 1999), stress-
related activation of the SNS might affect utero-placental perfusion, indirectly influencing fetal 
growth and, in turn, activating the fetal HPA axis (Rakers et al., 2017). Furthermore,  
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catecholamines might down-regulate 11β-HSD2 gene expression (Sarkar et al., 2001), thus 
possibly increasing fetal glucocorticoid exposure.  
In the current study, we focused on diurnal variations in maternal salivary alpha amylase 
(sAA), a non-invasive marker of SNS activity (Nater & Rohleder, 2009) which have shown to relate 
to previous history of miscarriage (Giesbrecht et al., 2013) and lower birth weight (Giesbrecht et 
al., 2015). Additionally, Rash et al. (2016) found that maternal prenatal sAA awakening response 
distinguished among 6-month-olds stress reactivity profiles, while Braithwaithe et al. (2017) 
showed that higher maternal prenatal sAA diurnal levels were associated with lower levels of 
distress to limits in  2-month-old boys.  
 
1.3 Prenatal IRS functioning and offspring’s stress reactivity 
Emerging data suggest that psychological distress, and in particular depressive symptoms, 
is associated with a dysregulation of the IRS as indicated by increased levels of inflammatory 
markers such as Interleukine-6 (IL-6) and C-reactive protein (CRP) both in non pregnant (Miller & 
Raison, 2016) and pregnant (Osborne & Monk, 2013) samples. However, knowledge about the 
role of the IRS in fetal programming is limited. Maternal inflammation during pregnancy has been 
shown to affect pregnancy and birth outcomes (e.g. Rusterholz et al., 2007; Coussons-Read et al., 
2012) and preliminary neuroimaging evidence suggests that higher maternal antenatal IL-6 levels 
are related to newborns’ functional and structural brain alterations (Graham et al., 2017; 
Rasmussen et al., 2018). Furthermore, Osborne and colleagues (2018) recently showed that 
higher maternal pro-inflammatory cytokines levels in late pregnancy were associated with 
newborns’ less optimal neurobehavioral function and 12-month-olds’ greater cortisol reactivity. 
 
1.3 Current study  
More research is needed to determine the routes by which maternal prenatal stress 
influences the fetus and its development. While biological and psychological stress measures are 
assumed to be markers of the same underlying construct, weak or null associations have been 
reported between self-reported measures and stress biomarkers across pregnancy (e.g. Harville et 
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al., 2009), suggesting that the effects of these factors on offspring neurodevelopment might occur 
through different pathways (O’Donnell & Meaney, 2017). Additionally, while it is known that 
complex interactions occur among the stress and immune systems, it is still unknown whether 
variations in maternal SNS and IRS functioning might affect fetal development. The current study 
begins to fill this gap by investigating the influence of variations in maternal self-reported 
depressive and anxiety symptoms, stress hormones and inflammatory markers in late pregnancy 
on birth outcomes and infant stress regulation in a sample of healthy women and infants. To our 
knowledge, the present study is unique in combining the assessment of multiple psychological and 
biological markers to better characterize the prenatal stress experience and investigate how 
different indices of prenatal stress relate to infant outcomes. We evaluated infants soon after birth 
in order to limit the effect of postnatal influences and we focused on late pregnancy as this is a 
period of rapid infant growth and brain development (Grossman et al., 2003) in which exposure to 
maternal stress signals is thought to influence the developing fetal stress response system (Davis 
et al., 2011) and is associated with later risk for emotional problems (Rice et al., 2007). 
Additionally, we focused on a low risk sample in order to limit possible confounding influences of 
additional risk factors associated with psychosocial adversity (e.g. teenage motherhood, 
unemployment, financial problems) and to provide novel data on the role of variations in maternal 
stress and inflammatory signals on offspring’s normative neurodevelopment that could be applied 
to the investigation of prenatal programming of abnormal development in high risk samples.  
 
2. Material and methods 
 
2.1 Participants and procedure 
Study participants included mother-infant dyads from the Effects of Depression on Infants 
(EDI) Study, an ongoing longitudinal investigation into the effects of maternal depression on 
infants’ bio-behavioral development. Women at 30-33 gestational weeks were consecutively 
recruited in three Italian hospitals and followed longitudinally. Prenatal inclusion criteria were: aged 
18-45 years, normotensive, with singleton uncomplicated pregnancy, non-smoker, not afflicted by 
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any disease or taking any chronic medications, and with no known substance/alcohol abuse 
problems or chronic psychiatric disorders (except for depression and anxiety). From the initial 
sample of 110 women, 6 were excluded because of intrauterine death and newborn health 
problems (N= 2), delivery in a different hospital (N= 1) and lack of behavioral data (N= 3). Most 
women (mean age=33.04, SD=3.83) were Italian (97.1%), well-educated (89.4% had at least high 
school diploma), middle-high class (94.8%), married (63.5%) or cohabiting (34.6%) and 
primiparous (89.4%). Infants (51.9% males) were mostly born by vaginal delivery (82.7%) and full 
term, except for two born, respectively, at 35 and 36 gestational weeks in good health. Women 
who were excluded from the postnatal phase did not differ from participants on any demographic 
variables, depression or anxiety scores.  
All pregnant women filled in two questionnaires on anxiety and depression and a 
demographic and pregnancy information form between 30-33 gestational weeks (mean gestational 
age=31.45; SD=1.40) and provided biological samples between 34-36 gestational weeks (mean 
gestational age=34.76; SD=1.12). Between 48-72 hours after delivery, infants’ behavioral and 
cortisol response to the heel-stick was assessed and women filled in a form on delivery and health. 
The Ethics Committee of the Scientific Institute Eugenio Medea, of University College London, and 
of the hospitals involved approved the study protocol.  
 
2.2 Maternal assessment 
Psychological assessment. Maternal antenatal depressive symptoms were evaluated 
through the 10-items Italian version (Benvenuti et al., 1999) of the Edinburgh Postnatal Depression 
Scale (EPDS; Cox et al.,1987), a self-report questionnaire widely used to screen for perinatal 
depression. Maternal anxiety symptoms were assessed through the 20-items Italian version 
(Pedrabissi & Santinello, 1989) of the state-anxiety subscale of the State-Trait Anxiety Inventory 
(STAI-S; Spielberger et al., 1970) a well-validated self-report measure, which evaluate anxiety 
symptoms experienced in the last few days.  
Health status. Both prenatally and postnatallly, participants were asked to fill in an ad-hoc 
form to collect health-related data and data related, respectively, to pregnancy (e.g. any 
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complication/risk/medical disorder etc.) and delivery (e.g. length of labor, analgesia etc.). 
Biological assessment. Ninety-seven women out of 104 consented to blood draw. Blood 
was drawn by venepuncture in the morning and kept refrigerated at +4° until it reached the 
Biological Lab of Medea Institute where serum was centrifuged, aliquoted, and stored at −80°. 
Biological assays for IL-6 and CRP levels were run in duplicate by using Quantikine High 
Sensitivity ELISA kits (R&D Systems Europe, LTD) at LaboSpace in Milan according to the 
manufacturer’s instructions. Intra-assay coefficient of variation (CV) was <6% for IL-6 and <3% for 
CRP, inter-assay CV was <10% for both markers.  
Saliva was collected at home on two consecutive days immediately upon awakening, 30 
minutes post-awakening and before going to bed to provide a general index of the diurnal pattern 
which is thought to better capture individual differences in the HPA axis and SNS activity 
(O’Donnell et al., 2013). Participants were instructed to collect whole unstimulated saliva samples 
by passive drool, to record time of collection on a diary and to avoid eating, tooth-brushing and 
exercising 30 minutes before collection. Women were reminded of the collection through pre-
scheduled phone callings and were instructed to employ a cooler for returning samples. The mean 
time from the awakening collection and the 30-minutes post-waking collection was 30.82 minutes 
on day 1 (SD=3.64, range: 20.00-60.00) and 31.44 minutes on day 2 (SD=6.81, range: 20.00-
90.00). All samples were visually inspected for contamination and diaries were checked for times 
and potentially interfering behaviors. As 1 pregnant woman collected the second sample more than 
one hour from awakening, this sample was excluded from analyses (e.g. O’Donnell, 2013). All 
saliva samples were stored frozen at -80° until assayed for salivary cortisol at the Biological Lab of 
Medea Institute, using a competitive high sensitivity enzyme immunoassay kit (Expanded Range 
High Sensitivity Cortisol EIA Kit, Salimetrics), and for sAA at the Salimetrics Centre of Excellence 
testing lab at Anglia Ruskin University, using a kinetic enzyme assay kit (Salimetrics α-Amylase 
Kinetic Enzyme Assay Kit). All samples for each woman were run in the same assay to minimize 
method variability. Salivary cortisol assays were run in duplicate, except for 2 samples with minimal 
volume. Average intra- and inter-assay coefficients were <6% and <8%, respectively. A random 
10% of the sAA assays were run in duplicate to confirm reliability. The intra-assay coefficient of 
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variation was < 3%.  
Cortisol and sAA have the opposite diurnal profile which is maintained during pregnancy: a 
sharp increase in cortisol concentrations after waking, is followed by a gradual decline across the 
day (Kivlighan et al., 2008), while sAA levels rapidly decrease after awakening and then gradually 
increase throughout the day (Giesbrecht et al., 2013). Four summary parameters were calculated 
to index different aspects of maternal cortisol and sAA diurnal activity, namely, waking levels, 
response to awakening, diurnal slope and total diurnal output. Specifically, as cortisol and sAA 
values at each time points across the two days were highly correlated (rs between .51 and .59 for 
cortisol and .55 to .78 for sAA), they were averaged and mean values were used to compute 
response to awakening (by subtracting waking values from the 30min post-waking levels) and  
diurnal slope (by subtracting the bedtime values from the waking values), as done in several prior 
studies (e.g. de Weerth et al., 2013). Additionally, daily average cortisol and sAA were calculated 
as the area under the curve (AUCg) using the trapezoid method with respect to the ground 
(Pruessner et al., 2003) for each day separately and, as the two values were highly correlated 
(r=.58, p<.001, for cortisol, r=.74, p<.001 for sAA), the mean of the two days was used. These 
composite measures are widely employed (e.g. De Weerth et al., 2013; Giesbrecht et al., 2017) 
and are thought to reflect different aspects of cortisol and sAA physiology. In particular, the 
response to awakening and diurnal slope reflect diurnal changes related to the HPA axis or SNS 
daily functioning, while the AUCg provide unique information about the overall secretion over the 
day (Adam & Kumari, 2009). As reported in previous studies (e.g. De Weerth et al., 2013), the 
awakening response and diurnal decline were moderately interrelated suggesting that a greater 
response to awakening was related to a flatter diurnal slope both for cortisol and sAA (respectively, 
r=-.47 and r=-.55, p<.001).  
 
2.3 Neonatal assessment 
Health and birth outcomes. Information on newborns’ health (i.e. gestational age, weight, 
body length and head circumference at birth, Apgar scores, any complication/abnormal sign, any 
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medication/treatment, breast or formula feeding, time of discharge) was extracted from medical 
records.   
Behavioral assessment. Newborns’ behaviour was videotaped during 10-minute baseline 
period, followed by the heel-stick and by 5-minutes recovery between 48 and 72 hours after birth 
(mean=57.06; SD=12.15). The average length of the heel stick was 3.99 minutes (SD=2.32). 
Newborns’ videotaped behavior was evaluated every 20-seconds on a 5-point scale (i.e. sleep, 
drowsy, awake and alert, awake and fussy, and crying), according to a modified version of a 
coding system employed by Davis et al. (2011). The highest state observed during each epoch 
was coded. As the length of the heel-stick was variable, the first 2 minutes from the beginning of 
the blood draw were coded for all infants to ensure complete data for the whole sample. The 
average state score for each of the three phases (10-minutes baseline, 2-minutes response, 5-
minutes recovery) was calculated. For approximately 10% of cases (N=10), two observers, 
independently coded newborn’s behaviour. Intra-class correlation was, respectively, equal to 1.0 
for baseline, 0.99 for response and 0.99 for recovery. Coders were blinded to all prenatal or 
postnatal data. 
Cortisol collection and assay. Salivary cortisol samples were collected after the baseline 
period before the beginning of the heel-stick, and after 20 and 40 minutes through specifically 
designed swab (SalivaBio Infant’s Swab, Salimetrics). Infants were not fed in the 30 minutes 
before the heel-stick (mean time from last feeding=68.50 minutes, SD=50.05) and were not 
handled during the study protocol besides that which was strictly required for the examination. 
Complete cortisol data were available for 49 infants while one or two sample were missing for 30 
infants and 25 infants had no data due to insufficient saliva volumes. Infants with complete, partial 
or missing data did not differ on any sociodemographic/maternal variables, infants-related 
variables or situational factors. Saliva samples were stored at -80º until assayed for cortisol 
according to the same procedure described for maternal cortisol. All samples from any individual 
infant were run on the same assay and in duplicate, excepted for 10 samples with minimal volume. 
The average intra- and inter-assay coefficients of variance were below 7% and 10%, respectively.  
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2.4 Statistical analyses 
Variables were first examined for outliers and skewness. Distributions of both maternal and 
infants’ biological markers were positively skewed even after removing samples greater than 3 SD 
from the mean (N=7 for maternal cortisol, N=4 for sAA, N=3 for IL-6, n=4 for infants’ cortisol), thus 
variables were natural log transformed to approximate normal distributions.  
To evaluate the potential effect of variables known to affect stress and immune physiology, 
preliminary Pearson correlations and univariate analysis of variance (ANOVA) were employed. All 
variables found to be significantly associated with the outcomes examined where included as 
covariates in all subsequent analyses. Maternal depression and anxiety were highly correlated  
(r=.60, p<.001), thus in order to avoid multicollinearity issues and as they are expected to differ in 
their underlying biology (O’Donnell & Meaney, 2017), they were entered separately in subsequent 
analyses. Analyses including maternal anxiety rather than depression, yielded comparable results 
and are reported in Supplementary Tables. 
Separate hierarchical regression analyses were performed to evaluate the effects of maternal 
prenatal psychological and biological stress markers on infant birth outcomes (i.e. birth weight, 
body length, and head circumference), while adjusting for covariates. Hierarchical Linear Models 
(HLMs) were estimated to investigate the influence of maternal prenatal stress measures on the 
trajectories of infants’ cortisol and behavioral reactivity, while accounting for the hierarchical 
structure of the data (three time-points nested within individuals). HLMs were specified at two 
levels where subjects were level 2 and time was level 1. Time was centered at baseline so that the 
model intercept represents the mean cortisol/behavioral state at baseline. Before fitting explanatory 
models including level-2 predictors, a baseline model of cortisol and behavioral response was fitted 
to describe the trajectory of infants’ response, including a linear and quadratic slope for time. A 
random intercept and a random linear slope were included to allow between-person variability. The 
explanatory variables were centered around the grand mean and entered in the model one-by-one. 
Gender was centered at males. Model fit was tested with likelihood deviance difference tests for 
nested models.  
Statistical analyses were performed using SPSS 24 and MLWiN. 
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3 Results  
3.1 Descriptive analyses and confounders 
Descriptive characteristics for all study variables are presented in Table 1, whereas 
correlations between prenatal variables, birth outcomes and stress reactivity are shown in Table 2.  
In a series of univariate correlation analyses we evaluated the associations between 
sociodemographic factors (maternal age, marital status, education and SES), pregnancy- and 
delivery-related factors (parity, mode of delivery, assisted delivery, length of labor), infant factors 
(gestational age, birth weight, gender, Apgar scores and postnatal age), situational factors (length 
of the heel-stick procedure, time of the day and time from last feeding) and newborn outcomes. 
Gestational age was associated with 20-min post-stressor cortisol levels (r=-.31, p<.05) and length 
of the heel-stick was positively related to both 20-min post-stressor cortisol levels (r=.30, p<.05) 
and averaged behavioral state during the response period r=.20, p<.05. Thus, they were included 
as covariates in HLMs. Additionally, while infant’s sex was not related to cortisol or behavior, there 
was a significant association between fetal sex and maternal waking cortisol levels (F(101,1)=5.02, 
p<.05). As sex-differences in the association between prenatal distress and infant cortisol have 
also been reported (e.g. Giesbrecth et al., 2017), infant’s gender was included as a covariate in 
subsequent analyses. Furthermore, gestational age, sex and maternal pre-pregnancy BMI were 
associated with birth outcomes, with infants with higher gestational ages, males and born from 
mothers with higher BMI, having greater anthropometric measures (ps<.05), and were included as 
covariates in hierarchical regression analyses.  
 
3.2 Association between maternal prenatal variables and birth outcomes 
As shown in Table 3, multiple hierarchical regression analyses revealed significant associations 
between both higher maternal sAA waking and AUCg levels and higher infant birth weight, as well 
as between higher IL-6 levels and smaller head circumference at birth, after controlling for pre-
pregnancy BMI, infant’s sex, and gestational age. No significant associations between maternal 
cortisol or maternal self-reported distress symptoms and any birth outcomes were found.  
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3.3 Association between maternal prenatal variables and newborns’ cortisol reactivity 
The unconditional means model for newborns cortisol showed significant variability at the 
individual level (level-2; σ2u0=0.042, p<.001) and between-occasions (level-1; σ2e0=0.057 p<.001). 
Infants displayed the expected cortisol response characterized by a significant linear slope of time 
(p<.05), and a marginally significant quadratic slope (p=.07). Also the random linear slope term 
was statistically significant (p<.001), suggesting significant between-person variability in the 
cortisol linear increase. Overall, this model resulted in a significant improvement in fit over the 
unconditional means model (deviance difference (4)=37.50, p<.001).   
Fixed independent effects of prenatal variables (i.e. depression, anxiety, cortisol, sAA, CRP 
and IL-6) on mean cortisol baseline levels and on the linear and quadratic slopes of time were 
tested separately, while controlling for gestational age, infant’s sex and length of the heel-stick. As 
shown in Table 4, maternal cortisol response to awakening (CAR) was significantly associated with 
both the linear and quadratic slopes of newborn’s cortisol response (p<.01). Specifically, as shown 
in Figure 1a, higher maternal CAR during pregnancy was related to a flatter cortisol response to 
the heel-stick, while lower maternal CAR was associated with greater infants’ cortisol reactivity. 
The inclusion of maternal CAR resulted in a significant improvement in the model fit (deviance 
difference (3)=9.173, p<.05). In contrast, there was no significant association between newborns’ 
cortisol response and, respectively, maternal self-reported distress symptoms, sAA, IL-6 or CRP 
levels.  
 
3.4 Association between maternal prenatal variables and newborns’ behavioral reactivity 
The unconditional means model for newborns behavioral regulation showed significant 
variability between-occasions (level-1; σ2e0=0.136, p<.001), while variability at the individual level 
was not significant (level-2; σ2u0=0.006, p>.05). There was a significant behavioral change in 
response to the heel-stick, as indexed by the significant linear and quadratic slopes of time (both 
ps<.001). The variance of the linear slope term was statistically significant (p<.001), suggesting 
significant between-person variability in the behavioral linear increase. Additionally, the significant 
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positive association (p<.05) between the random effects of intercept at level-2 and the linear slope 
indicates that there was a greater increased in the behavioral indices of distress in response to the 
heel-stick in individuals with higher behavioral states at baseline. Overall, this model results in a 
significant improvement in fit over the unconditional means model (deviance difference (4)=106.46, 
p<.001).   
Fixed independent effects of prenatal variables on mean behavioral state at baseline and 
change over time were tested separately, while controlling for covariates. Maternal diurnal slope 
was significantly associated with both the linear and quadratic slopes of newborns’ behavioral 
response (p<.05, Table 6). Specifically, as shown in Figure 1b, a lower maternal cortisol diurnal 
slope was associated with greater behavioral reactivity in the infant, while a higher maternal diurnal 
slope was related to a less marked behavioral reactivity. The inclusion of maternal diurnal slope 
results in a significant improvement of the model fit (deviance difference (3)=7.8, p=.05). 
Additionally, maternal cortisol at awakening was significantly associated with the linear slope of 
newborns’ response (p<.05), with lower levels of cortisol being associated with a steeper increase 
in behavioral response to the heel-stick, while higher levels of cortisol were related to a flatter 
increase. However, the inclusion of maternal cortisol at awakening did not significantly improve the 
model fit (deviance difference (3)=6.34, p=.10).  
Maternal self-reported distress symptoms, sAA, IL-6 and CRP levels were not significantly 
associated with infants’ behavioral regulation.  
 
4. Discussion 
The current study was aimed at elucidating the influences of psychological and biological 
indices of maternal stress in late pregnancy on infants’ birth outcomes and stress regulation. 
Findings provide further support for an association between maternal prenatal diurnal cortisol and 
infants’ stress reactivity. Furthermore, the results add to the limited literature on alternative 
biological mechanisms involved in fetal programming, by highlighting significant associations 
between variations in markers of maternal SNS and IRS functioning and birth outcomes in a low-
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risk sample of mother-infant dyads. In contrast, no significant associations between maternal self-
reported distress symptoms and infant outcomes were found.  
 
4.1 Prenatal maternal factors and birth outcomes 
Markers of maternal IRS and SNS functioning during pregnancy were significantly 
associated with newborns’ anthropometric measures, such as head circumference and birth 
weight, whereas cortisol levels and self-reported distress symptoms were not related to any birth 
outcomes.      
The significant association between higher prenatal maternal IL-6 levels and smaller head 
circumference at birth is a novel finding. While observational epidemiological studies report that 
maternal inflammatory response to infections during pregnancy are associated with increased risk 
of neuropsychiatric disorders, such as schizophrenia, in the resulting offspring (e.g. Estes & 
McAllister 2016), the extent to which there is a programming effect of maternal cytokines is  
unknown. Head circumference is considered a marker for intrauterine brain development and is 
associated with later cognitive function (Broekman et al., 2009). Thus, our findings are consistent 
with results from animal studies (e.g. Meyer et al., 2006) and preliminary brain imaging studies in 
humans (Grahman et al., 2017; Rasmussen et al., 2018) suggesting that maternal inflammation 
can affect fetal growth and neural development. Whether directly transferred  through the placenta 
or indirectly affecting the fetal development through placental inflammation, elevated cytokines are 
hypothesized to act at multiple levels of the fetal brain, affecting neurogenesis, gliogenesis and the 
neurotransmitter systems (reviewed in Rakers et al., 2017). An alternative mechanism is that 
epigenetic mechanisms could mediate the impact of prenatal maternal inflammation on fetal brain 
development with potentially long-lasting effects as suggested by results of animal studies 
(Kundakovic & Jaric, 2017). Future efforts are needed to elucidate the role of maternal IL-6 levels 
in influencing rates of fetal growth and brain development in humans. 
Consistent with previous findings (Osborne & Monk, 2013), we reported a positive 
association between IL-6 levels and self-reported depressive symptoms in a low-risk sample of 
women free from any medication or medical conditions. This result was specific for maternal 
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depression, rather than anxiety, and is in line with accumulating evidence for a role of inflammation 
in the vulnerability for depression (Miller & Raison 2016), thus encouraging further research into a 
possible inflammatory pathway from prenatal depressive symptoms to altered offspring outcomes. 
It is important to note that self-reported depressive symptoms were not associated with birth 
outcomes. This is consistent with a number of studies that show null or weak associations between 
prenatal continuous depression measures and adverse birth outcomes in low-risk samples 
(Goedhart et al., 2010)(Grote et al., 2010).  
Higher maternal prenatal sAA levels at awakening and throughout the day were associated 
with higher infant birth weight. Our findings are partially in line with the only published study on the 
link between maternal sAA and birth outcomes (Giesbrecht et al., 2015), which showed an 
association between greater birth weight and higher maternal sAA waking levels and decrease 
after waking. Replication in larger cohorts is needed before the significance of these preliminary 
findings can be discussed. We might speculate that mild elevations in maternal sAA indicate an 
increased SNS involvement to ensure maternal and fetal energetic resources for growth during late 
normative pregnancy, in line with evidence (e.g. DiPietro et al., 2011) suggesting that adjustments 
in maternal neuroendocrine functioning over gestation are mainly generated and supported by the 
feto-placental unit.  
Lastly, the lack of significant associations between birth outcomes and cortisol levels is in 
line with results of larger studies (e.g. Goedhart et al., 2010). 
 
4.2 Prenatal maternal factors and newborns’ stress reactivity 
Infants displayed the expected increase in cortisol levels and behavioural distress in 
response to the heel-stick in the neonatal period. In line with our hypotheses, findings support a 
role of variations in maternal diurnal cortisol rhythm, and in particular in maternal CAR and diurnal 
slope, during late pregnancy in influencing offspring’s stress reactivity.  
Specifically, maternal CAR was related to newborns’ cortisol reactivity, with infants 
prenatally exposed to a higher maternal CAR showing a flatter cortisol response to stress. Only 
two studies have examined the role of maternal prenatal CAR on infant stress reactivity. In line with 
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our findings, Giesbrecht et al. (2017) reported a significant association between a higher maternal 
CAR and blunted cortisol reactivity in 3-month old boys, whereas De Weerth et al. (2013) related a 
higher maternal CAR to impaired infants’ cortisol habituation, as shown by a stable cortisol 
response over repeated maternal separations. Taken together, these findings might suggest that 
an increased maternal CAR during pregnancy might be associated with an impairment of the 
infants’ capacity to flexibly react to stress. 
Maternal cortisol diurnal slope during pregnancy was significantly associated with 
newborns’ behavioral response to the heel-prick, with a smaller decline in maternal cortisol levels 
throughout the day being associated with  greater infant behavioral reactivity. These findings are 
novel; while previous studies have shown greater behavioral stress reactivity in infants prenatally 
exposed to higher maternal cortisol (e.g. Davis et al., 2011; Werner et al., 2013), none of these 
studies included diurnal cortisol measures.  
Both the CAR and diurnal slope are key components of the diurnal cortisol rhythm that are 
relatively maintained and sensitive to psychological distress during pregnancy (Kivlighan et al., 
2008). However, their role in fetal programming is still largely unknown. Thus it is unclear why 
different measures of maternal prenatal diurnal cortisol relate to different aspects of infants stress 
reactivity (i.e. physiological or behavioral). Interestingly, in line with previous reports (e.g. De 
Weerth et al., 2013) maternal CAR and cortisol decline were moderately correlated, with higher 
CARs being related to flatter cortisol declines. Therefore, it would seem that an alteration of 
maternal diurnal cortisol pattern is, to a certain extent, associated with both a dampened cortisol 
reactivity and an amplified behavioral response to stress in the infants soon after birth. As a lack of 
coordination between adrenocortical and behavioral responses has been associated with later 
psychopathology (e.g. Quas et al. 2000), it would be important to evaluate whether neonatal 
profiles of reactivity persist and are predictive of later patterns of stress reactivity and later 
emotional or behavioral dysregulation.  
Questions remain about the mechanisms underlying the associations between diurnal 
variation in maternal cortisol diurnal measures and patterns of infants stress reactivity. On the one 
hand, we might speculate that both a higher than typical CAR or a flatter cortisol diurnal decline 
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might result in a greater amount of cortisol reaching the fetus and potentially alter the set-point of 
fetal stress response systems. Consistently with this, animal studies suggest that the rise in 
glucocorticoids at the circadian peak saturates the 11β-HSD2 enzyme, leading to greater placental 
transfer of maternal glucocorticoids to the fetus (Venihaki et al., 2000). Alternatively, while the 
stress reactivity patterns observed a few hours after birth can be considered largely independent of 
postnatal influences, hereditary transmission might still explain the observed associations, with 
mother-infant shared genes accounting for variation in both maternal diurnal cortisol patterns and 
newborns’ stress response (e.g. Van Hulle et al., 2012).  
Some non-significant results are worth mentioning. First, in contrast with previous reports 
(e.g. Davis et al., 2011), we did not find any effect of maternal depressive or anxiety symptoms on 
infant stress regulation. There are a number of reasons for these null findings, including the limited 
sample size which might have reduced the chance to detect a true effect, and the possibility that 
mild variations in maternal distress have little to no effect on the developing foetus, as compared to 
stronger exposures (e.g. Vedhara et al., 2012). It is also possible that the effects of prenatal 
maternal distress on offspring stress reactivity might emerge later in development (O’Donnell et al., 
2013). It is noteworthy that few studies examined both antenatal anxiety and depression in the 
same sample and generally comparable associations between anxiety or depression and children 
stress-related physiology have been reported (e.g. Davis et al., 2011; Werner et al., 2013; 
O’Donnell et al., 2013). However, few reports showed a stronger effect for maternal antenatal 
anxiety symptoms as compared to depressive in predicting children cortisol diurnal patterns 
(O’Connor et al., 2005) and reactivity (Grant et al., 2009). More studies are needed to determine 
the prenatal risk phenotype that might be more implicated in child development, as well as 
elucidate the underlying mechanisms. 
Second, consistent with prior work (e.g. Davis et al., 2011; Baibazarova et al., 2013) 
maternal prenatal cortisol and self-reported symptoms were not significantly associated with infant 
outcomes, thus calling into question the role of cortisol as a mediator of fetal programming. It is 
possible that the HPA axis-resetting occurring during pregnancy might overcome our ability to 
identify significant associations between endocrine and self-reports stress measures. Or, relatively 
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low levels of distress might not significantly affect the HPA axis regulation. Nonetheless, it is 
noteworthy that we do report a significant association between maternal depressive symptoms and 
IL-6 levels, thus possibly suggesting that inflammatory markers might be a more promising avenue 
for future research.  
Our preliminary results do not support a role of the SNS and the IRS in influencing newborn 
stress reactivity. To our knowledge, only Osborne and colleagues (2018) investigated the role of 
maternal prenatal inflammation on offspring’s stress reactivity in humans and reported unadjusted 
positive correlations between prenatal maternal inflammatory markers and 12-month-olds’ cortisol 
levels following the immunization in a sample of clinically depressed women and healthy controls. 
While sample size was comparable to the current one, methodological heterogeneity in the 
composition of the samples and in infants’ ages might account for different results. Further 
replication of the current findings in different cohorts is needed. Similarly, prenatal maternal sAA 
levels were not associated with newborns’ stress reactivity. Only two published studies have thus 
far examined this association, reporting significant links between maternal sAA levels in early-mid 
gestation and, respectively, 2-month-olds’ negative emotionality (Braithwaite et al., 2017) and 6-
month-olds stress-reactivity profiles (Rash et al., 2016) but  no significant links with sAA in late 
pregnancy (Rash et al., 2016).  
 
4.3 Limitations 
Despite the strengths of the present study, such as a prospective design, the inclusion of 
multiple stress markers, several confounders and the neonatal assessment soon after birth, the 
interpretation of findings should be cautious due to several limitations. First, data are based on a 
relatively small middle-high SES community sample evaluated in late pregnancy and levels of self-
reported distress were relatively low, thus limiting generalizability of results to high-risk populations 
and different gestational windows. We focused on late pregnancy because it is a period of 
particularly rapid fetal growth and brain development including neuronal differentiation, 
synaptogenesis and myelination (Grossman et al., 2003), which make the fetus particularly 
susceptible to environmental influences. We cannot rule out that effects earlier in pregnancy may 
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be different. Secondly, we cannot determine whether the observed associations are specific to the 
third trimester or might be the result of a continuous prenatal exposure. Our results are not 
inconsistent with studies suggesting a stronger and specific effect of prenatal stress exposure on 
the outcomes examined in late pregnancy as compared to earlier exposure (e.g. Davis et al., 2011; 
Vedhara et al., 2012), but without measuring multiple time points across pregnancy we cannot 
directly address this hypothesis. Notably, Giesbrecht and colleagues (2017) recently reported 
stronger effects of early exposure to maternal diurnal cortisol on infant cortisol reactivity, as 
compared to later exposures. As recently highlighted by Zyjlmans and colleagues (2015), future 
studies should include multiple time point across gestation, in order to better characterize prenatal 
stress exposure and test for timing effects. Additionally, as a rise in cortisol levels has been 
reported as gestation progresses (Davis et al., 2011) and as cortisol levels were unrelated to 
psychological measures of distress, we cannot exclude the possibility that cortisol data might be 
primarily determined by pregnancy-related alterations. 
Third, maternal salivary samples were collected at home and compliance with the protocol 
was not objectively measured. Fourth, as previously reported (Egliston et al., 2007), obtaining 
sufficient saliva volumes from newborns was a challenge, thus leading to limited sample size for 
cortisol analyses. HLMs were employed in order to maximize the number of infants included in the 
final analyses and obtain reliable estimates of effects despite missing values for one or more time-
points. However, conclusions that can be drawn from the current study are to be regarded as 
preliminary and require replication in different and larger cohorts. Additionally, it cannot be 
excluded that newborns’ cortisol reactivity might be masked by a still-unresolved cortisol response 
to delivery, although duration of labor and mode of delivery were unrelated to infants cortisol levels.  
Lastly, as we did not use a relevant genetically informative design (Rice et al., in press) and 
the study is observational, we cannot rule out possible pleiotropic effects of shared genes which 
both influence maternal stress levels and infants’ outcomes, as well as unmeasured confounding 
and causal inferences cannot be drawn.   
 
4.4 Conclusions 
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Taken together, the current results suggest that variations in maternal stress hormones and 
inflammation in late pregnancy might influence fetal growth and development with possible 
implications for later outcomes. However, the weak or null association between psychological and 
biological measures of stress underlines the incomplete picture of the mechanisms through which 
prenatal distress may be transmitted to the foetus and affect later development, and highlights the 
needs for further research. We believe that a better understanding of the complex pathways 
underlying fetal programming will not only improve our knowledge of typical and atypical fetal 
development but will also have important implications for the development of effective targeted 
intervention. 
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Table 1 – Descriptive statistics for study variables at the prenatal and postnatal assessment   
 
Note: AUCg, area under the curve with respect to the ground; sAA, salivary alpha amylase; CRP, C-Reactive 
Protein; IL-6, Interleukine-6.
Study Variable Mean SD Range 
Prenatal    
Maternal cortisol (µg/dl)    
Waking 0.38 0.13 0.13-0.83 
Waking +30’  0.50 0.15 0.10-0.91 
Bedtime 0.18 0.06 0.01-0.41 
Response to waking 0.12 0.16 -0.52-0.52 
Diurnal slope 0.20 0.13 -0.12-.70 
AUCg 262.63 58.59 83.76-442.71 
Maternal sAA (U/ml)    
Waking 69.84 64.75 3.00-463.84 
Waking +30’  47.74 37.90 2.80-190.10 
Bedtime 99.14 80.95 3.28-562.71 
Response to waking -21.07 52.65 -350.94-119.97 
Diurnal slope -28.48 85.67 -405.11-298.32 
AUCg 3601.07 690.76 1777.74-5394.20 
Maternal CRP (ng/ml) 3730.16 2766.02 480.04-11244.10 
Maternal IL-6 (pg/ml) 1.68 1.04 0.48-6.47 
Maternal depression (EPDS) 5.41 4.44 0-19 
Maternal anxiety (STAI-S) 35.22 8.95 20-64 
Postnatal    
Gestational age (weeks) 39.48 1.25 35-42 
Birth weight (grams) 3296.83 443.27 2170-4440 
Body Length (cm) 50.08 1.88 45-54 
Head Circumference (cm) 34.48 1.30 31.50-39.50 
Newborns’ cortisol (µg/dl)    
Baseline  0.66 0.45 0.06-2.27 
20-min post-stressor  0.83 0.63 0.15-3.00 
40-min post-stressor 0.82 0.73 0.17-3.04 
Newborns’ behavior    
Baseline  2.15 1.16 1.00-4.63 
Response   3.69 1.10 1.00-5.00 
Recovery  2.47 1.17 1.00-4.80 
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Table 2 – Bivariate correlations among prenatal variables, birth outcomes and infant stress reactivity 
Note: AUCg, area under the curve with respect to the ground; sAA, salivary alpha amylase; CRP, C-Reactive Protein; IL-6, Interleukine-6. 
* p<.05; **p<.01, t p=.06, p>.05 was considered non-significant. 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
1. Prenatal EPDS              
 
2. Prenatal STAI-S .60**             
 
3. Prenatal Cortisol 
AUCg  -.17 .00            
 
4. Prenatal sAA AUCg  .07 .19 .24*            
5. Prenatal IL-6 .20* .19 .13 .19           
6. Prenatal CRP .13 .15 .11 -.01 .31**          
7. Birth weight  .10 .05 -.03 .18t .03 .25*         
8. Body length .05 .00 -.05 .08 -.03 .14 .90**        
9. Head Circumference .12 -.01 .02 .06 -.18 .09 .63** .59**       
10. Cortisol baseline -.22t -.17 .01 -.00 -.10 .06 .14 .11 .05      
11. Cortisol post 20’ -.08 -.11 -.03 .04 -.14 -.14 -.02 -.06 .03 .27     
12. Cortisol post 40’ -.08 -.13 .04 -.02 -.07 .04 -.06 -.08 .00 .01 .80**    
13. Behavioral baseline -.00 -.07 .09 .01 -.01 .02 -.01 .00 -.13 .31** .21 .17   
14. Behavioral response -.10 -.17 -.05 .11 -.06 -.09 .13 .07 .08 .00 .21 .03 .01  
15. Behavioral recovery -.16 -.08 .12 .10 .02 -.07 .11 .13 .08 .12 .30* .11 .14 .51** 
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Table 3 – Hierarchical linear regression analyses predicting weight and head circumference at birth 
Note: AUCg, area under the curve with respect to the ground; sAA, salivary alpha amylase. 
 
 
   Birth weight   Head circumference 
 Cortisol AUCg sAA AUCg sAA waking IL-6 CRP Cortisol AUCg sAA AUCg IL-6 CRP 
 β p β p β p β p β p β p β p β p β p 
Step 1:                    
Gender -.19 .03 -.18 .04 -.18 .04 -.13 .17 -.14 .14 -.17 .08 -.17 .08 -.10 .34 -.14 .19 
Pre-pregnancy BMI .23 .01 .22 .01 .22 .01 .16 .09 .19 .05 .20 .04 .19 .06 .11 .30 .12 .27 
Gestational Age .41 .00 .40 .00 .40 000 .43 .00 .42 .00 .24 .01 .23 .02 .27 .01 .25 .02 
ΔR2 for step 1 .28 .00 .26 .00 .26 .00 .25 .00 .24 .00 .15 .00 .14 .00 .11 .03 .10 .03 
Fmodel 13.14 .00 12.50 .00 12.50 .00 9.70 .00 9.64 .00 5.28 .00 5.03 .00 3.26 .03 3.25 .03 
Step 2:                    
EPDS .12 .14 .14 .10 .14 .10 .13 .16 .15 .11 .12 .20 .15 .12 .15 .16 .16 .12 
ΔR2 for step 2 .01 .14 .02 .10 .02 .10 .02 .16 .02 .11 .01 .20 .02 .12 .02 .16 .02 .12 
Fmodel 10.51 .00 10.21 .00 10.21 .00 7.85 .00 8.01 .00 4.41 .00 4.44 .00 2.97 .02 3.08 .02 
Step 3:                    
Biological predictors -.06 .46 .18 .03 .17 .05 -.06 .52 .09 .36 -.09 .35 .02 .82 -.33 .00 -.01 .96 
ΔR2 for step 3 .00 .46 .03 .03 .03 .05 .00 .52 .01 .36 .01 .35 .00 .82 .10 .00 .00 .96 
Fmodel 8.48 .00 9.36 .00 9.18 .00 6.32 .00 6.56 .00 3.70 .00 3.53 .01 4.62 .00 2.43 .04 
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Table 4 – Full prediction models for the effects of maternal depression (EPDS) and cortisol diurnal indices on infants’ cortisol response 
 Model 1 Waking 
Model 2 
CAR 
Model 3 
Diurnal slope 
Model 4 
AUCg 
 Estimate (SE) p Estimate (SE) p Estimate (SE) p Estimate (SE) p 
Fixed effects         
Intercept 0.508 (0.039) <.001 0.508 (0.038) <.001 0.504 (0.038) <.001 0.505 (0.046) <.001 
Gender -0.053 (0.052) 0.31 -0.050 (0.051) 0.32 -0.046 (0.050) 0.36 -0.051 (0.051) 0.32 
Gestational Age -0.022 (0.019) 0.25 -0.025 (0.020) 0.21 -0.027 (0.019) 0.16 -0.021 (0.020) 0.29 
Heel-stick length 0.001 (0.011) 0.98 0.001 (0.010) 0.93 0.004 (0.011) 0.69 0.001 (0.011) 0.91 
EPDS  -0.075 (0.040) 0.06 -0.068 (0.038) 0.08 -0.063 (0.039) 0.11 -0.071 (0.040) 0.08 
Cortisol -0.135 (0.315) 0.66 0.245 (0.253) 0.33 0.337 (0.286) 0.24 0.000 (0.001) 0.94 
Linear -0.005 (0.008) 0.54 0.008 (0.003) <.001 0.013 (0.005) <.01 0.003 (0.003) 0.27 
EPDS  0.002 (0.003) 0.47 0.001 (0.003) 0.59 0.001 (0.003) 0.77 0.001 (0.003) 0.73 
Cortisol 0.029 (0.023) 0.20 -0.042 (0.017) <.01 0.035 (0.020) 0.08 -0.000 (0.000) 0.48 
Quadratic 0.000 (0.000) 0.41 -0.000 (0.000) <.001 -0.000 (0.000) <.05 -0.000 (0.000) 0.51 
EPDS  -0.000 (0.000) 0.65 -0.000 (0.000) 0.79 -0.000 (0.000) 0.94 -0.000 (0.000) 0.95 
Cortisol -0.001 (0.000) 0.17 0.001 (0.000) <.01 0.001 (0.000) 0.09 0.000 (0.000) 0.32 
Random effects         
Level 2 (individual)         
Intercept variance 0.034(0.010) <.001 0.036(0.010) <.001 0.034(0.010) <.001 0.034(0.010) <.001 
Linear slope variance 0.000(0.000) <.001 0.000(0.000) <.001 0.000(0.000) <.001 0.000(0.000) <.001 
Intercept/Linear slope    
covariance 
-0.000(0.000) 0.09 -0.001(0.000) 0.07 -0.000(0.000) 0.07 -0.000(0.000) 0.09 
Level 1 (occasions)         
Intercept variance 0.022(0.005) <.001 0.020(0.004) <.001 0.022(0.005) <.001 0.022(0.005) <.001 
Note: Cortisol diurnal indices are examined separately in Model 1-4. CAR, cortisol awakening response, AUCg, area under the curve with respect to the ground;  
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Table 5 – Full prediction models for the effects of maternal depression (EPDS) and cortisol diurnal indices on infants’ behavioural response 
 Model 1 Waking 
Model 2 
CAR 
Model 3 
Diurnal slope 
Model 4 
AUCg 
 Estimate (SE) p Estimate (SE) p Estimate (SE) p Estimate (SE) p 
Fixed effects         
Intercept 1.086 (0.040) <.001 1.090 (0.040) <.001 1.086 (0.040) <.001 1.086 (0.040) <.001 
Gender 0.001 (0.046) 0.99 0.001 (0.046) 0.99 0.004 (0.046) 0.98 0.008 (0.046) 0.86 
Gestational Age 0.020 (0.018) 0.28 0.014 (0.019) 0.46 0.020 (0.018) 0.23 0.022 (0.019) 0.22 
Heel-stick length 0.009 (0.010) 0.39 0.011 (0.010) 0.24 0.009 (0.010) 0.36 0.012 (0.010) 0.21 
EPDS  0.002 (0.046) 0.96 0.003 (0.046) 0.95 0.003 (0.046) 0.95 0.008 (0.047) 0.86 
Cortisol 0.180 (0.380) 0.63 0.264 (0.322) 0.41 0.274 (0.353) 0.44 0.001 (0.001) 0.35 
Linear 0.047 (0.008) <.001 0.029 (0.003) <.001 0.038 (0.004) <.001 0.048 (0.011) <.001 
EPDS  -0.002 (0.003) 0.50 -0.001 (0.003) 0.79 -0.002 (0.003) 0.56 -0.002 (0.003) 0.56 
Cortisol -0.055 (0.025) <.05 -0.003 (0.022) 0.88 -0.056 (0.024) <.05 -0.000 (0.000) 0.08 
Quadratic -0.000 (0.000) <.001 -0.000 (0.000) <.001 -0.001 (0.000) <.001 -0.001 (0.000) <.001 
EPDS  0.000 (0.000) 0.83 -0.000 (0.000) 0.92 0.000 (0.000) 0.90 0.000 (0.000) 0.86 
Cortisol 0.001 (0.000) 0.07 0.000 (0.000) 0.92 0.001 (0.000) <.05 0.000 (0.000) 0.07 
Random effects         
Level 2 (individual)         
Intercept variance 0.058(0.017) <.001 0.056(0.017) <.001 0.058(0.017) <.001 0.058(0.017) <.001 
Linear slope variance 0.000(0.000) <.001 0.000(0.000) <.001 0.000(0.000) <.001 0.000(0.000) <.001 
Intercept/Linear slope    
covariance 
-0.001(0.000) <.01 -0.001(0.000) <.01 -0.001(0.000) <.01 -0.001(0.000) <.01 
Level 1 (occasions)         
Intercept variance 0.055(0.008) <.001 0.057(0.008) <.001 0.055(0.008) <.001 0.056(0.008) <.001 
Note: Cortisol diurnal indices are examined separately in Model 1-4. CAR, cortisol awakening response, AUCg, area under the curve with respect to the ground;  
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Figure 1 – a) Cortisol values before and after the heel-stick for newborns whose mothers had higher (+1 SD) and lower (-1SD) cortisol awakening 
response (CAR), after adjusting for covariates; b) Averaged behavioural state before, during and after the heel-stick for newborns exposed 
prenatally to higher (+1 SD) and lower (-1SD) maternal cortisol diurnal slope, after adjusting for covariates.  
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Supplementary Tables 
Table 3a – Hierarchical linear regression analyses predicting weight and head circumference at birth 
 
 
Note: AUCg, area under the curve with respect to the ground; sAA, salivary alpha amylase. 
 
   Birth weight   Head circumference 
 Cortisol AUCg sAA AUCg sAA waking IL-6 CRP Cortisol AUCg sAA AUCg IL-6 CRP 
 β p β p β p β p β p β p β p β p β p 
Step 1:                    
Gender -.19 .03 -.18 .04 -.18 .04 -.13 .17 -.14 .13 -.20 .03 -.20 .03 -.12 .26 -.15 .14 
Pre-pregnancy BMI .23 .01 .22 .01 .22 .01 .16 .09 .18 .05 .13 .18 .12 .23 .03 .75 .04 .67 
Gestational Age .41 .00 .40 .00 .40 000 .43 .00 .41 .00 .27 .01 .26 .01 .29 .01 .27 .01 
ΔR2 for step 1 .28 .00 .26 .00 .26 .00 .25 .00 .24 .00 .14 .00 .13 .00 .10 .03 .10 .03 
Fmodel 13.12 .00 12.47 .00 12.47 .00 9.70 .00 9.62 .00 5.27 .00 5.09 .00 3.13 .03 3.09 .03 
Step 2:                    
STAI-S .01 .95 .03 .71 .03 .71 .05 .63 .04 .64 -.07 .46 -.03 .72 -.01 .93 -.02 .85 
ΔR2 for step 2 .00 .95 .00 .71 .00 .71 .00 .63 .00 .64 .00 .46 .00 .72 .00 .93 .00 .85 
Fmodel 9.74 .00 9.31 .00 9.31 .00 7.27 .00 7.20 .00 4.07 .00 3.82 .01 2.32 .06 2.30 .06 
Step 3:                    
Biological predictors -.08 .36 .18 .03 .16 .05 -.05 .63 .11 .29 -.09 .38 .08 .40 -.28 .01 -.03 .82 
ΔR2 for step 3 .01 .36 .03 .03 .02 .05 .00 .63 .01 .29 .01 .38 .01 .40 .07 .01 .00 .82 
Fmodel 7.95 .00 8.66 .00 8.30 .00 5.81 .00 6.00 .00 3.41 .00 3.19 .01 3.39 .01 1.83 .11 
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Table 4a – Full prediction models for the effects of maternal anxiety (STAI-S) and cortisol diurnal indices on infants’ cortisol response 
 Model 1 Waking 
Model 2 
CAR 
Model 3 
Diurnal slope 
Model 4 
AUCg 
 Estimate (SE) p Estimate (SE) p Estimate (SE) p Estimate (SE) p 
Fixed effects         
Intercept 0.509 (0.039) <.001 0.510 (0.038) <.001 0.507 (0.038) <.001 0.508 (0.039) <.001 
Gender -0.055 (0.053) 0.29 -0.057 (0.051) 0.26 -0.051 (0.050) 0.31 -0.054 (0.051) 0.29 
Gestational Age -0.021 (0.019) 0.27 -0.026 (0.020) 0.19 -0.028 (0.020) 0.15 -0.024 (0.020) 0.23 
Heel-stick length 0.000 (0.000) 0.82 0.000 (0.000) 0.82 0.000 (0.000) 0.55 0.000 (0.000) 0.68 
STAI-S  -0.179 (0.124) 0.15 -0.179 (0.122) 0.14 -0.163 (0.122) 0.18 -0.172 (0.123) 0.16 
Cortisol -0.051 (0.312) 0.86 0.284 (0.255) 0.27 0.394 (0.285) 0.17 0.000 (0.001) 0.67 
Linear -0.012 (0.036) 0.74 -0.005 (0.033) 0.55 0.014 (0.034) 0.68 0.009 (0.035) 0.79 
STAI-S  0.002 (0.010) 0.80 0.003 (0.009) 0.76 -0.000 (0.009) 0.99 0.001 (0.010) 0.16 
Cortisol 0.026 (0.023) 0.24 -0.043 (0.017) <.01 -0.036 (0.020) 0.07 -0.000 (0.000) 0.67 
Quadratic 0.000 (0.000) 0.68 -0.000 (0.001) 0.34 -0.000 (0.001) 0.75 -0.000 (0.001) 0.82 
STAI-S  -0.000 (0.000) 0.79 -0.000 (0.000) 0.74 -0.000 (0.000) 0.97 -0.000 (0.000) 0.84 
Cortisol -0.001 (0.000) 0.18 0.001 (0.000) <.01 0.001 (0.000) 0.08 0.000 (0.000) 0.27 
Random effects         
Level 2 (individual)         
Intercept variance 0.035(0.010) <.001 0.037(0.010) <.001 0.036(0.010) <.001 0.036(0.011) <.001 
Linear slope variance 0.000(0.000) <.001 0.000(0.000) <.001 0.000(0.000) <.001 0.000(0.000) <.001 
Intercept/Linear slope    
covariance 
-0.000(0.000) 0.08 -0.001(0.000) 0.07 -0.000(0.000) 0.06 -0.000(0.000) 0.06 
Level 1 (occasions)         
Intercept variance 0.022(0.005) <.001 0.020(0.004) <.001 0.022(0.005) <.001 0.022(0.005) <.001 
Note: Cortisol diurnal indices are examined separately in Model 1-4. CAR, cortisol awakening response, AUCg, area under the curve with respect to the ground;  
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Table 5a – Full prediction models for the effects of maternal anxiety (STAI-S) and cortisol diurnal indices on infants’ behavioural response 
 Model 1 Waking 
Model 2 
CAR 
Model 3 
Diurnal slope 
Model 4 
AUCg 
 Estimate (SE) p Estimate (SE) p Estimate (SE) p Estimate (SE) p 
Fixed effects         
Intercept 1.086 (0.040) <.001 1.090 (0.040) <.001 1.090 (0.040) <.001 1.088 (0.040) <.001 
Gender -0.010 (0.046) 0.82 -0.010 (0.046) 0.84 -0.007 (0.046) 0.88 -0.002 (0.046) 0.97 
Gestational Age 0.021 (0.018) 0.28 0.014 (0.019) 0.46 0.021 (0.018) 0.25 0.022 (0.018) 0.23 
Heel-stick length 0.009 (0.010) 0.36 0.012 (0.010) 0.23 0.009 (0.010) 0.36 0.013 (0.010) 0.21 
STAI-S  -0.104 (0.139) 0.45 -0.100 (0.140) 0.48 -0.100 (0.139) 0.47 -0.097 (0.140) 0.86 
Cortisol 0.150 (0.372) 0.69 0.277 (0.320) 0.39 0.248 (0.349) 0.48 0.001 (0.001) 0.35 
Linear 0.046 (0.008) <.001 0.029 (0.003) <.001 0.038 (0.004) <.001 0.047 (0.011) <.001 
STAI-S -0.008 (0.009) 0.41 -0.007 (0.010) 0.49 -0.008 (0.009) 0.40 -0.007 (0.010) 0.49 
Cortisol -0.053 (0.025) <.05 -0.002 (0.022) 0.88 -0.056 (0.023) <.05 -0.000 (0.000) 0.09 
Quadratic -0.001 (0.000) <.001 -0.000 (0.000) <.001 -0.001 (0.000) <.001 -0.001 (0.000) <.001 
STAI-S 0.000 (0.000) 0.39 0.000 (0.000) 0.47 0.000 (0.000) 0.38 0.000 (0.000) 0.47 
Cortisol 0.001 (0.000) 0.07 0.000 (0.000) 0.76 0.001 (0.000) <.05 0.000 (0.000) 0.07 
Random effects         
Level 2 (individual)         
Intercept variance 0.057(0.017) <.001 0.055(0.017) <.001 0.057(0.017) <.001 0.057(0.017) <.001 
Linear slope variance 0.000(0.000) <.001 0.000(0.000) <.001 0.000(0.000) <.001 0.000(0.000) <.001 
Intercept/Linear slope    
covariance 
-0.001(0.000) <.01 -0.001(0.000) <.01 -0.001(0.000) <.01 -0.001(0.000) <.01 
Level 1 (occasions)         
Intercept variance 0.055(0.008) <.001 0.057(0.008) <.001 0.055(0.008) <.001 0.055(0.008) <.001 
Note: Cortisol diurnal indices are examined separately in Model 1-4. CAR, cortisol awakening response, AUCg, area under the curve with respect to the ground;
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